IMMU-02. LOCOREGIONAL HER2CAR T CELLS FOR PEDIATRIC CENTRAL NERVOUS SYSTEM TUMORS: PRECLINICAL EFFICACY TO TOLERABILITY IN FIRST PATIENTNicholas A. Vitanza, Michael C. Jensen, Adam Beebe et al.|Neuro-Oncology|2019Cited by 2